Frisch Financial Group, Inc. Moderna, Inc. Transaction History

Frisch Financial Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$126.46 - $235.05 $112,549 - $209,194	-890 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$225.82 - $368.51 $38,389 - $62,646	-170 Reduced 16.04%	890 $226,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $235,214 - $513,538	1,060 New	1,060 $408,000

1,037

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Frisch Financial Group, Inc. with notifications on news.